Abatacept Information - September 8, 2008

FDA Approves Arthritis Drug

December 26, 2005 - Topics fda, arthritis, disease, abatacept and studies
Bristol-Myers Squibb Co. gains U.S. approval to sell a new type of drug for treating the painful swelling of rheumatoid arthritis, called Orencia.

Revenue could top $1 billion a year, according to industry analysts

read more >>

New Rheumatoid Drug Approved For Sale

December 26, 2005 - Topics disease, abatacept, studies, immune and arthritis
Bristol-Myers Squibb Co. gains U.S. approval to sell a new type of drug for treating the painful swelling of rheumatoid arthritis, called Orencia.

Revenue could top $1 billion a year, according to industry analysts

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use